πŸ›’ Your Cart

πŸš€ Free shipping on orders over $200  |  99%+ Purity Guaranteed  |  Same-Day Dispatch Before 2PM EST
πŸ“ US-Based Research Peptide Supplier  |  info@truetide.com
πŸ§ͺ Research Stacks CAS: Blend βœ“ 99%+ Purity

KLOW Blend
KPV + BPC-157 + TB-500 + GHK-Cu Research Stack

β˜…β˜…β˜…β˜…β˜…4.8 / 5  Β·  Quad-peptide healing research stack

Select Size

$99
100mg blend
βœ“
99%+ purity, independently verified by HPLC & mass spectrometry
❄
Lyophilized vials β€” shipped with cold pack, stable at βˆ’20Β°C long term
πŸ“„
Certificate of Analysis included with every order
🚚
Same-day dispatch on orders before 2PM EST
πŸ”’
Discreet, unmarked packaging β€” research-grade handling
⚠️ For Research Use Only. KLOW Blend is not approved for human consumption or therapeutic use. This product is sold exclusively as a research chemical for in vitro and laboratory research only.

What is KLOW?

KLOW is a curated research blend combining four peptides with complementary anti-inflammatory and tissue regenerative mechanisms: KPV (Ξ±-MSH fragment, melanocortin pathway), BPC-157 (GI + tendon repair), TB-500 / Thymosin Beta-4 (actin modulation, systemic repair), and GHK-Cu (copper-tripeptide collagen remodeling). Researchers use KLOW to study the synergistic effects of these four pathways simultaneously in complex healing and inflammation models.

Quad-peptide research formulation

KPV β€” Melanocortin

MC1R/MC3R agonism suppresses NF-ΞΊB-driven cytokine cascades. Targets systemic and localized inflammation.

BPC-157 β€” GI & Tendon

Upregulates VEGF and NO pathways for vascular repair. Well-characterized in tendon, ligament, and GI mucosal research.

TB-500 β€” Actin Dynamics

Thymosin Beta-4 modulates G-actin sequestration to promote cell migration and systemic tissue remodeling.

GHK-Cu β€” ECM Remodeling

Copper-tripeptide stimulates collagen synthesis, MMP activity, and angiogenesis for extracellular matrix repair.

Complementary Mechanisms Review

Individual published studies on each KLOW component demonstrate non-overlapping mechanisms: KPV (NF-ΞΊB), BPC-157 (VEGF/NO), TB-500 (actin), GHK-Cu (TGF-Ξ²/MMP) β€” forming a rationale for combined research protocols.

See individual compound references

BPC-157 + TB-500 Synergy

Multiple rodent studies show BPC-157 and TB-500 combination produces superior healing outcomes vs either peptide alone in tendon repair models.

J Appl Physiol. 2014;116(7):840–848

GHK-Cu Wound Healing

Pickart et al. published over 30 years of GHK-Cu wound healing research documenting its role in collagen stimulation, TGF-Ξ² modulation, and MMP-regulated tissue remodeling.

Biomolecules. 2015;5(3):1552–1560

Research Stack Protocols

Individual component dosing should reference each peptide's own literature (BPC-157: 200-400 Β΅g/kg, TB-500: 2-4mg/site, GHK-Cu: 50-200 Β΅g/site, KPV: 1-10 Β΅g). KLOW provides pre-measured blend for consistent ratio research. Endpoints typically include histological repair scoring, cytokine panels, and imaging-based tissue metrics.

Research Design: KLOW enables single-administration multi-target studies. Individual compound controls are recommended in study design.
ComponentsKPV Β· BPC-157 Β· TB-500 Β· GHK-Cu
FormatPre-measured blend, lyophilized
Purity (each component)β‰₯99% by HPLC
AppearanceWhite lyophilized powder
Storageβˆ’20Β°C, desiccated
ApplicationIn vitro / in vivo tissue repair research